Cargando…
Markedly prolonged disease course, with breakthrough seizures, in a glioma with an isolated IDH1 mutation
Autores principales: | Drumm, Michael, Templer, Jessica W, Tate, Matthew, Jennings, Lawrence, Horbinski, Craig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809516/ https://www.ncbi.nlm.nih.gov/pubmed/35128400 http://dx.doi.org/10.1093/noajnl/vdac004 |
Ejemplares similares
-
Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient
por: McCord, Matthew, et al.
Publicado: (2021) -
H3K27M-mutant, hemispheric diffuse glioma in an adult patient with prolonged survival
por: Chia, Noel, et al.
Publicado: (2021) -
IDH-mutant astrocytoma with EGFR amplification—Genomic profiling in four cases and review of literature
por: Umphlett, Melissa, et al.
Publicado: (2022) -
Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome
por: File, Danielle M., et al.
Publicado: (2020) -
Using Advanced Molecular Profiling to Identify the Origin of and Tailor Treatment for an Intracranial Mass of Unknown Primary
por: Martinez, Francisco, et al.
Publicado: (2021)